Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chymotrypsin-like proteasome activity refers to the proteolytic function of the β5 subunit of the 20S proteasome core particle, responsible for cleaving peptide bonds after large hydrophobic amino acid residues. It plays a critical role in protein degradation, immune function, and cellular homeostasis, making it a therapeutic target in diseases like cancer. Assays typically measure this activity using fluorogenic substrates like Suc-Leu-Leu-Val-Tyr-AMC.
Inhibition of chymotrypsin-like proteolytic activity of the proteasome β5 subunit.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chymotrypsin-like Proteasome Activity (n/a).